Early Alert: Positive Pressure Breathing Device Issue from Baxter
Baxter has issued an alert regarding Volara system patient circuits that may experience air and medication leaks from the nebulizer cup. These leaks can result in reduced oxygenation and ineffective delivery of nebulized medication during therapy.
Baxter, healthcare providers utilizing the Volara system, respiratory therapists, and hospital risk management departments.
The reported malfunction directly compromises the efficacy of respiratory therapy and patient oxygenation levels. This may necessitate a Class I recall if the FDA determines the malfunction poses a significant risk of serious adverse health consequences. Regulatory teams should anticipate heightened scrutiny regarding the manufacturing and quality control of these specific patient circuits.
Clinical engineering and QA teams should immediately identify and sequester affected Volara system patient circuits. Compliance departments should monitor for formal recall classification and ensure all field safety notices are documented within the firm's CAPA system.
Volara system patient circuits may leak air and medication from the nebulizer cup during therapy, leading to reduced oxygenation and ineffective nebulization.
Open in openFDA / FDA.gov